Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24 USD | +0.04% | -8.47% | +204.18% |
05-31 | Jasper Therapeutics, Inc. to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 | CI |
05-20 | Transcript : Jasper Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+204.18% | 362M | |
+48.79% | 781B | |
-7.23% | 350B | |
+19.43% | 330B | |
+7.18% | 293B | |
+17.30% | 248B | |
+0.08% | 221B | |
+11.44% | 217B | |
+4.53% | 162B | |
-3.92% | 157B |
- Stock Market
- Equities
- JSPR Stock
- News Jasper Therapeutics, Inc.
- Jasper Therapeutics Names New CEO; Shares Climb